Limitations of Direct Surgical Aortic Valve Sizing
with symptomatic aortic stenosis undergoing SAVR and quantify the differential area. Then, we calculate the valve areas after implantation of a balloon-expandable valve (TAVR) and compare these valve areas. These data may yield important insights into the real and perceived hemodynamic differences between SAVR and TAVR, yet also highlight how surgical decision making may be improved by advanced preoperative imaging.
Methods
All patients who underwent isolated SAVR with a tissue valve and received preoperative MDCT imaging between June 2012 and December 2014 at our institution were analyzed in this study (n=101). In brief, all patients had symptomatic severe aortic stenosis, had an at least intermediate surgical risk treated as part of the PARTNER II or SURTAVI trial (STS score 3% to 8%), 6, 7 or treated commercially with SAVR, and the native aortic annulus size was ≥18 mm or ≤27 mm as measured by echocardiography. Important exclusion criteria were patients with bicuspid aortic valve anatomy, end-stage renal disease, cardiogenic shock, active infection, and recent stroke. Additional exclusion criteria for this analysis were aortic root enlargement (n=2) and missing (n=5) or inadequate MDCT images (n=8) and valve-invalve procedures (n=8). A total of n=78 patients were included in this analysis. Clinical information was collected in patient charts and surgical records; CT images were analyzed for all patients. Postoperative transthoracic echocardiograms were performed before discharge. The study was approved by the Columbia University Institutional Review Board and need for informed consent was waived.
Aortic Annulus Measurements and Calculations
To detect the most precise measurement, end-systolic and end-diastolic MDCT scans were analyzed by a cardiologist experienced in CT imaging and blinded to clinical data. The aortic annulus was defined as the plane of the virtual circumferential ring containing the basal attachment points of the 3 aortic valve leaflets. The MDCT Acquisition Protocol is depicted in the Data Supplement. Ellipticity was assessed using the manually assessed minimal and maximal diameter using the following formula 
Surgical Aortic Valve Replacement
All operations were performed using a standard, median sternotomy approach, using cardiopulmonary bypass with mild systemic hypothermia (30-34°C). Myocardial protection was achieved with del Nido solution (650-1000 mL antegrade single dose) cardioplegia. Intraoperative assessment of the aortic annulus size was conducted after resection of the aortic valve cusps and complete debridement of the calcifications. The annular end of the sizing obturator was inserted into the annulus and the complete fit of the largest possible sizer was defined as optimal valve choice. The replica end of the sizer (where applicable) was used to verify the correct valve size. No patient underwent an aortic root enlargement procedure, as previously noted. The annular end of the valve sizer was measured for each valve (see Table IIa in the Data Supplement); for both Mosaic and MagnaPerimount valve sizers, the annular end of the sizer corresponds to the outer diameter of the stent frame of the surgical valve.
Valve Sizing Scale for MDCT Measurements
Each valve sizer for each manufacturer and valve size were individually measured, and it was found that the outer dimension of the annular portion of the sizer corresponds to the outer stent diameter of a valve and also corresponded to the labeled valve size. Therefore, if an annulus allowed a 21 sizer to be placed, a #21 valve of that manufacturer would be chosen, which represents the outer stent frame diameter in millimeters; the outer stent diameter for both Edwards and The sizing chart above assumes that the annular end of the sizer (the sizer end that fits entirely through the annulus) cannot be forced into an annulus smaller than the sizer. For example, a 21.5-mm annulus would be sized to a size 21 valve rather than a size 23 valve.
After assessment of the strongest correlation of MDCT measurement-derived diameters at the annulus with the implanted valve size and in concordance with recent literature, 1,9,10 SAP (Systolic, at Annulus, Perimeter derived diameter) was used for further analysis. See Table IIIA and IIIB in the Data Supplement for results of the correlation and Figure II in the Data Supplement displaying the diameter predicted by MDCT-SAP measurements by implanted valve size.
Patients were then stratified according to suggested valve size by SAP in relation to actual valve size: group CT-same, MDCT valve size, and implanted valve size in accordance, group CT-Lg) larger valve size by preoperative MDCT measurement than actual implanted valve, and group CT-Sm) smaller valve size by MDCT than implanted valve.
Comparison of Valve Sizes: Implanted (GOA SAVR ) Versus MDCT (GOA SAVR-CT ) Versus TAVR (GOA TAVR )
Although outer stent diameters may be equivalent, valve sizes from different manufacturers have unequal inner stent diameters; therefore, we calculated the geometric orifice area (GOA) and indexed GOA (GOA/body surface area) to quantify the difference between the choice of valve size for intraoperative versus MDCT-based sizing. The GOAs are calculated from the true inner diameter 11 of the valves, which is smaller than the reported inner stent diameter because this value does not include the space occupied by the valve leaflets if these are attached inside the valve (see Table IIB in the Data Supplement and compare to internal stent diameters in Table IIC in the Data Supplement). GOA was calculated as follows: (true internal diameter/2) 2 ×π. The GOA is, therefore, specific for each valve brand and size.
In a second step, we determined the SAPIEN 3 (Edwards Lifesciences, Irvine, CA) valve size for each patient based on SAPderived measurements and compared the theoretical difference with corresponding values of the implanted surgical valve. See Table IIE in the Data Supplement displaying the mean nominal GOA for each TAVR valve size.
The SAPIEN 3 is a balloon-expandable stented valve used for TAVR. We assumed complete expansion of the chosen valve through balloon dilation. 12 As opposed to SAVR, the SAPIEN 3 valve will theoretically expand to the size of the native aortic annulus dimensions (as assessed by MDCT). We calculated the achieved area by TAVR accordingly (GOA derived from SAP diameter, GOA TAVR ) and compared these values with the GOAs from the implanted valve (GOA SAVR ) and the theoretical SAVR valve after MDCT sizing (GOA SAVR -CT ). To account for true inner stent diameter of the SAPIEN 3 valves, we assumed a total leaflet and frame thickness of 2 mm (reducing SAP d for each SAPIEN 3 valve size by 2 mm), and GOA TAVR was calculated as follows: ((SAP d−2 mm)/2) 2 ×π. See Table IIE in the Data Supplement.
Statistical Analysis
Descriptive statistics were used to summarize patients' characteristics. Continuous variables were reported as mean and SD or median and range or interquantile range and compared between the 2 groups using 2-sample independent t tests or Mann-Whitney U test (nonnormal data). Categorical variables were summarized as frequencies (%) and compared using 
Results

Patient Demographics and Baseline Characteristics
As displayed in Table 1 , baseline demographics and comorbidities were comparable between the groups. No patients underwent previous cardiac surgery. The Mosaic valve (Medtronic, Minneapolis, MN) was predominant in group CT-Sm, whereas the Carpentier Edwards valves were the most commonly implanted valves in groups CT-same and CT-Lg ( Figure 1 ).
Intraoperative Surgical Versus MDCT-Based Valve Sizing
The GOAs based on implanted surgical valve size (GOA SAVR ) and indexed GOA SAVR were comparable across all groups ( 
Echocardiographic Findings
The preoperative and postoperative echocardiographic (Echo) data for all patients are shown in Table 3 
; the mean gradient from the 3-year CoreValve Pivotal High Risk Trial similarly showed a mean composite gradient of all valve sizes of 7.62±3.57 mm Hg. 14 There was no significant difference in ellipticity between the groups.
Postoperative Outcomes
There was only one case of mild paravalvular leak and one patient who died within 30 days after the procedure, both in group CT-Sm. All postoperative variables, including postoperative cerebrovascular accident and postoperative acute kidney injury, were comparable between the 3 groups. Postoperative outcomes are displayed in Table IV in the Data Supplement.
Discussion
Optimal valve sizing is paramount in aortic valve replacement-be it SAVR or TAVR-for procedural success and All values mean±SD. CT indicates computed tomography; GOA, geometric orifice area; MDCT, multidetector computerized tomography; SAP diameter, systolic, at annulus, perimeter derived diameter; SAVR, surgical aortic valve replacement; and TAVR, transcatheter aortic valve replacement. Limitations of Direct Surgical Aortic Valve Sizing optimal hemodynamics. Patients undergoing both conventional surgical and transcatheter valve replacement may suffer clinical consequences of annular undersizing, specifically paravalvular leak, leaflet dysfunction, worsened hemodynamics, or possible patient-prosthesis mismatch. Conversely, significant annular oversizing may result in inability to seat the valve or coronary obstruction in SAVR, or central regurgitation or annular rupture in TAVR. 15 The importance of annular sizing in TAVR to achieve optimal outcomes has been widely established in the literature and in clinical practice, 16 and MDCT has currently become the standard of care for optimal annular sizing. Systolic-phase MDCT can be used to determine the optimal deployment area preprocedure; however, the same sizing imaging algorithm and rigor has not been applied to patients undergoing SAVR. As a result, optimal sizing in SAVR has relied on intraoperative measurements after calcium debridement, which may or may not correlate with MDCT-based sizing. The ability to optimally size surgical prostheses has taken on much greater importance in recent years after recognition that hemodynamics after SAVR may be inferior to TAVR, mainly because of geometric constraints of the prostheses themselves. The primary objective of the current study was to provide a detailed anatomic, comparative analysis of annular sizing of patients undergoing SAVR using both preoperative MDCT and intraoperative annular sizing, with the hypothesis that intraoperative sizing may yield smaller annular sizes compared with MDCT-based sizing.
In the current study of a cohort of SAVR patients with preoperative MDCT imaging, we found that (1) 43.6% of patients Figure 2 . A-C, Box-and-whiskers plot displaying GOA SAVR , GOA SAVR-CT , and GOA TAVR for group CT-same, -Lg and -Sm, respectively. In (A), as previously defined for group CT-same, GOA SAVR equals GOA SAVR-CT . (*P<0.05 vs GOA SAVR, #P<0.05 vs GOA SAVR-CT). CT indicates computed tomography; GOA, geometric orifice area; SAVR, surgical aortic valve replacement; and TAVR, transcatheter aortic valve replacement. received valves of the same size as predicted by MDCT (group CT-same), 41% of patients received a valve smaller than that predicted by MDCT (group CT-Lg), and 15.4% of patients received a valve larger than that predicted by MDCT; (2) systolic perimeter derived D at the nadir of the annulus (SAP) provided the closest estimation of valve prosthesis chosen in both TAVR and SAVR; (3) no short-term clinical or echocardiographic consequence was apparent from undersizing surgical valves; and (4) theoretical placement of a balloon-expandable valve expanded to native patient annular area was associated with significantly larger GOA than either intraoperative valve sizing or MDCT-based SAVR sizing in all patients.
For quantitative comparisons of the resulting differences in size among different valve brands and between SAVR and TAVR valves, we calculated the respective GOAs from true inner diameters. 11 The differences in GOAs if TAVR valves were implanted are significant between all groups, and the mean achievable GOAs are significantly larger compared with the GOAs by SAVR. Interestingly, GOA TAVR was slightly smaller than GOA SAVR-CT for 3 patients in group CT-Lg and between 4.96% and 9.06% smaller than GOA SAVR for another 3 patients in group CT-Sm. GOA TAVR in group CT-same was 25.3% larger, and 40.6% larger in group CT-Lg compared with GOA SAVR . Remarkably, even in group CT-Sm where MDCT suggests a smaller valve size, the mean GOA TAVR was still 14.6% larger than GOA SAVR . The differences in GOA TAVR to GOA SAVR correspond to 1.1 to 3.5 SAVR valve sizes. Group CT-Sm consists of the patients who would have received a smaller valve by MDCT sizing (GOA SAVR-CT <GOA SAVR ), and most patients in this group (n=10, 83.3%) had Medtronic valves implanted (Table 1) . These have a smaller GOA per valve size compared with the Carpentier Edwards valves used in our study population. Therefore, the resulting GOA TAVR / GOA SAVR-CT ratio is largest for group CT-Sm ( Table 2; Table  IIA through IIE) . Although the immediate postoperative echocardiographic parameters were comparable between the groups with the implanted valve sizes, the clear differences in GOA TAVR suggest significantly better hemodynamic results, if these patients had undergone TAVR and were sized by MDCT.
In our findings, MDCT measurements of the aortic annulus differ substantially from intraoperative direct measurements, and intraoperative evaluation of the aortic root dimensions resulted in smaller dimensions in most cases. This can be explained by many factors. First, the complex shape of the aortic annulus is not assessed in its physiological state intraoperatively, because the left ventricle is arrested and decompressed. Precise intraoperative sizing can depend on numerous structural conditions including angle of the aorta, adequacy of exposure, compliance of the annulus, left ventricular outflow tract calcium, and degree and quality of calcium debridement. A frequent limitation in intraoperative valve sizing is the presence of a calcified sinotubular junction or aortic sinus wall, which prevents the rigid valve sizer from entering the sinus without risk of aortic injury; instead, the surgeon may choose a smaller valve to minimize surgical risk. Second, there are key differences in the exact location at which intraoperative annular sizing occurs. The aortic annulus complex is a 3-dimensional crown-shaped fibrous structure defined by the outline of each leaflet cusp ( Figure III in the Data Supplement). Intraoperatively, the annulus is identified as a ridge of fibrous tissue onto which sutures are placed. The annular portion of the sizer is grossly inserted into the annulus such that the sizer just fits beyond this plane bounded by both the commissures and nadir of the ridges. In contrast, a basal ring is defined for MDCT TAVR sizing as a virtual ring located in a single plane bounded by the nadir of each cusp. This plane can be located multiple millimeters below the surgical fibrous annulus described above. It is likely that the surgical annulus measured by the annular sizer and the MDCT-defined basal ring do not correspond in many patients, such as those with severe calcifications of the left ventricular outflow tract, eccentric calcium, or a severely elliptical annular shape. Moreover, the surgical sizer likely underestimates the true annular perimeter by virtue of its inability to accurately account for coverage of perimeter that exists at the top of each commissure, above the basal ring ( Figure IV in the Data Supplement). Third, the discrete, ordinal nature of SAVR valve sizing further exacerbates annular undersizing: valve sizes are typically provided in sizes 19 to 29 mm with valves available every 2 mm. For native annular sizes in between a particular valve size, the default practice for many cardiac surgeons is to choose the smaller size rather than attempt to force a larger valve. Both balloon-expandable and self-expanding TAVR delivery systems, however, allow expansion of the valve frame to at least native annular area/perimeter in most cases (dependent on calcium burden) and is not bound by manufacturing constraints. This difference, as well as the absence of a thick sewing ring that occupies vital space in the inner stent frame, accounts for a large part of the discrepancy in GOA between SAVR and TAVR. Finally, the phenomenon of stretching an aortic annulus is not possible in SAVR with a rigid frame, other than to perform an aortic root enlargement procedure, whereas postdilatation of TAVR routinely is performed to oversize a valve. This is particularly relevant in the SAPIEN 3 balloon-expandable valve, which allows for overexpansion via foreshortening of the cobalt chromium frame. ECG-gated MDCT is comparable to a live imaging of the aortic annulus, whereas general anesthesia, calcified sinotubular junction, and the limitations mentioned above of a rigid sizer do not allow such precise measurements in a physiological state of the heart. To account for the fact that the sewing ring of the surgical valve can rest higher in the aortic sinus and thus allow a larger valve, the aortic annulus at 2 mm above the anatomic annulus was also measured and included in the correlation between the method of annular sizing (area, perimeter, and manually assessed) and surgical valve size to see what method showed strongest correlation with intraoperative sizing (see Data Supplement).
In our cohort, 15.4% of patients received a smaller valve when compared with MDCT measurements (group CT-Sm), whereas 41% received a larger valve size (group CT-Lg). Review of the literature reveals few studies on this subject that are limited by small case numbers, lack of advanced imaging, and reports before the advent of TAVR. Dashkevich et al 17 found no systematic difference between intraoperative diameters assessed with a Hegar dilator and MDCT measurements of the aortic annulus by calculating the diameter from minimal and maximal measured diameters. However, pre-and intraoperative transesophageal echocardiography in a small sample group guided this study. Wang et al 8 compared aortic annulus diameters measured by intraoperative transesophageal echocardiography versus preoperative CT images with direct intraoperative sizing of the aortic annulus diameter with sizers in 227 consecutive patients undergoing proximal aortic surgery. Annular sizes by CT sizing were larger in 72.2% of cases. In 46.3% of these cases, the difference was more than one TAVR valve size. Sizing was based on the effective diameter calculated from the basal ring area, which corresponds to SAA or DAA in our nomenclature (see Figures I and IV in the Data Supplement). Because only a small portion of CT scans was ECG-gated, these results are not directly comparable to our numbers and correlation coefficients.
Although intraoperative measurements are usually considered the gold standard for comparison with CT measurements, we suggest that CT leads to more precise measurements of aortic annulus dimensions and should be considered the reference standard instead. MDCT measurements lead to 25% larger GOAs in 41% of the patients (n=32) and 22% smaller GOAs for 15.4% of the study population (n=12). Preoperative MDCT assessment may not be necessary or cost effective for all SAVR patients but may be particularly helpful in certain subgroups of patients at risk for patient-prosthesis mismatch including those with small body size, predilection for extreme calcium (ie, end-stage renal disease patients), or obese patients. It is our belief that preoperative MDCT sizing may be a useful decision making tool for annular root enlargement to optimize hemodynamics in SAVR, particularly in patients at risk for patient-prosthesis mismatch.
Because future perspectives with MDCT sizing becoming increasingly relevant, the possibility of 3-dimensional printing to aid intraoperative planning may become more widespread. As already used by some specialties (eg, orthopedic surgery, congenital cardiac surgery), 18, 19 3-dimension-printed models of the aortic root may aid in assessment of valve anatomy, sizing, orientation, and other difficulties associated with SAVR. The resolution of current printers has improved and is actually higher than MDCT resolution, is cheap relative to the intervention, and can be performed rapidly (ie, within 1 hour). Future advances in 3-dimensional printing may include integration of calcification by imaging, variation of biomaterials in the model, and prototyping for practice procedures.
Limitations
The incidence of patient-prosthesis mismatch could not be assessed in our cohort because the effective orifice area was not calculated; in clinical practice, effective orifice area represents a smaller value than GOA despite the best predictive estimates. In our study and in theory, the GOA represents a simple measurement to compare different valve sizes of different valve types. We used it as basis to quantify the hypothetical hemodynamic benefits of larger valves. The clinical impact of these theoretical results remains unknown, but they underline the potential to optimize hemodynamics by TAVR in patients eligible for both procedures.
Conclusions
Preoperative MDCT measurements differ significantly from intraoperative direct measurements of the aortic annulus, and these differences can be quantified by comparison of GOAs. Implanted SAVR valves based on intraoperative sizing are smaller relative to MDCT-based sizing in 41% of patients, and the potential GOA was between 25.3% and 40.6% larger if patients had undergone TAVR. The clinical impact of these theoretical results requires further studies with systematic clinical and echocardiographic follow-up.
